FAWNA HUFFMAN: Open Payments
NPI 1356680862 · MOSCOW, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$179 in 10 payments from 6 companies in 2025. Trend: 2023 $696 · 2024 $0 · 2025 $179
Food & beverage: $179
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 3 | $45 |
| ABBVIE INC. | 2 | $35 |
| Janssen Biotech, Inc. | 2 | $35 |
| Teleflex LLC | 1 | $27 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $21 |
| Medtronic, Inc. | 1 | $16 |
Products named: BOTOX, ERLEADA, ORGOVYX, BARRIGEL, PYLARIFY, INTERSTIM, GEMTESA.
Industry payments across ID — which companies pay providers there.
